Delivery Order SPE2DB20D1100-SPE2DB25FE2X7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,339.62 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, was competitively awarded with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units) valued at $7,555.01. This competitively awarded, firm fixed-price delivery order is set to complete by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,322.95 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count supply) with a firm fixed price arrangement. This order was competitively awarded without set-aside designation and is scheduled for completion on September 16, 2025, one day after the award date of September 15, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at approximately $23.8k to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Xulane 150-35 mcg/day transdermal patches (3-pack units) with a ceiling value of $6,836.59 under a firm fixed price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.60 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package). The contract, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $62,112.32 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count packages) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (three-count units) with a ceiling value of $1,402.17. This firm fixed-price delivery order, which is expected to be completed by August 13, 2025, represents a non-competitive award issued under an existing contract vehicle. The award specifies Conshohocken, Pennsylvania as the place of performance, which aligns with...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2X7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,776.65 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This competitively awarded, firm fixed-price contract was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The award utilizes no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the supply of brand-name and generic medications, specialty drugs, vaccines, and related medical supplies across multiple therapeutic domains. The DLA Troop Support Medical utilizes this framework to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with flexible and scalable pharmaceutical procurement capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/26/25 |